Does a positive serum GABA receptor IgG/IgA result prove autoimmune encephalitis?

A serum GABA-receptor antibody result should be treated as a diagnostic clue, not proof of pathogenic autoimmune encephalitis. This is especially important when results are serum-only, low titre, clinically discordant, or reported as IgA rather than disease-validated IgG.

Clinical and diagnostic evidence

• In a selected cell-based-assay-positive cohort, 33% of patients ultimately had an alternative diagnosis. Among cases judged false positive, 94% lacked CSF cell-based-assay confirmation, versus 25% of true-positive cases; none of the false-positive cases showed supportive tissue immunofluorescence.
• In multicentre GABA-A receptor assay validation, only 8 of 26 suspected specimens were confirmed. Low-titre, serum-only reactivity was less clinically specific.
• A credible diagnosis requires a compatible subacute CNS syndrome plus objective evidence such as focal neurologic findings, otherwise unexplained seizures, CSF pleocytosis, or encephalitic MRI abnormalities, with reasonable exclusion of alternative causes. EEG can support seizure or focal-dysfunction assessment.

Antibody specificity and confirmatory testing

• The established autoimmune encephalitis evidence concerns antigen-specific GABA receptor IgG. The diagnostic or pathogenic significance of serum GABA-A receptor IgA remains unestablished.
• Paired serum and CSF testing is preferred because sensitivity and serum–CSF concordance vary by antibody and assay. Antigen-specific cell-based assays supported by neuronal-surface/neuropil staining on tissue-based testing provide more persuasive evidence than an isolated serum assay.
• Phenotype matters: GABA-A receptor IgG encephalitis commonly features severe or drug-refractory seizures and often multifocal cortical–subcortical MRI lesions. Typical GABA-B receptor disease generally has CSF antibody detection; serum-positive/CSF-negative discordance therefore warrants particular caution.

Bottom line

• The overall claim is supported: serum GABA-receptor positivity alone does not establish autoimmune encephalitis. Clinical significance depends on validated IgG specificity, paired-specimen and orthogonal assay confirmation, and a concordant objective CNS inflammatory/encephalitic syndrome.